Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

Clinical trial NCT01159964 · TERMINATED

Trial details

NCT number: NCT01159964
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2010-07-20
Primary completion: 2011-10-19
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.